Radiopharm Theranostics Ltd (RAD) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.80x
Radiopharm Theranostics Ltd (RAD) has a Cash Flow-to-Debt Ratio of -0.80x as of June 2026, meaning its operating cash flow of AU$-30.11 Million could theoretically repay -1% of its total liabilities (AU$37.81 Million) in one year. See RAD free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.80x
Operating CF / Total Liabilities
Operating Cash Flow
AU$-30.11 Million
AUD
Total Liabilities
AU$37.81 Million
AUD
Data as of
Jun 2026
Most recent filing
Radiopharm Theranostics Ltd Cash Flow-to-Debt Ratio (2021–2026)
Historical debt coverage capacity for Radiopharm Theranostics Ltd across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Radiopharm Theranostics Ltd.
Annual Cash Flow-to-Debt Ratio for Radiopharm Theranostics Ltd (2021–2026)
Year-by-year debt coverage analysis for Radiopharm Theranostics Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -1.40x | AU$-52.78 Million | AU$37.81 Million | ▼ -66.1% |
| 2025 | -0.84x | AU$-36.65 Million | AU$43.61 Million | ▼ -63.4% |
| 2024 | -0.51x | AU$-22.98 Million | AU$44.68 Million | ▲ +34.9% |
| 2023 | -0.79x | AU$-23.20 Million | AU$29.37 Million | ▼ -62.8% |
| 2022 | -0.49x | AU$-9.91 Million | AU$20.42 Million | ▼ -133.2% |
| 2021 | -0.21x | AU$-32.91K | AU$158.14K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.